Table 1.
Baseline characteristics of patients at hospital admission
| All patients (n = 52) | |
|---|---|
| Age (years), median (IQR) | 71.5 (13.75) |
| Sex (male) | 40 (76.9%) |
| Comorbidities | |
| None | 14 (26.9%) |
| Hypertension | 31 (59.6%) |
| Diabetes | 11 (21.2%) |
| Cardiac failure | 2 (3.8%) |
| Ischemic heart disease | 3 (5.8%) |
| BMI ≥ 30 kg/m2 | 9 (17.3%) |
| COPD | 11 (21.2%) |
| Active smoker | 3 (5.8%) |
| Active cancer | 3 (5.8%) |
| HIV infection | 1 (1.9%) |
| CKD III | 7 (13.5%) |
| Clinical characteristics at admission | |
| Fever | 44 (84.6%) |
| Pneumonia | 49 (94.25%) |
| Dyspnea | 39 (75.5%) |
| FiO2 (%), median (IQR) | 35 (39) |
| SatO2 (%), median (IQR) | 95 (6) |
| PaO2/FIO2, mean ± SD | 243 ± 155 |
| SOFA, mean ± SD | 5.78 ± 3.26 |
| Days from onset to hospital admission, median (IQR) | 7 (5) |
| Days from onset to ICU, median (IQR) | 10 (4) |
| ACEIs | 11 (21.2%) |
| ARBs | 8 (15.4%) |
| Mean baseline creatinine (mg/dL), median (IQR) | 0.96(0.43) |
| Median baseline eGFR CKD-EPI (ml/min), mean ± SD | 76.52 ± 20 |
Median (IQR)/n(%)/mean ± SD
BMI Body Mass Index, COPD chronic obstructive pulmonary disease, HIV human immunodeficiency virus, CKD chronic kidney disease, ACEIs angiotensin converting enzyme inhibitors, ARBs angiotensin II receptor blockers, PaFiO2 arterial blood oxygen pressure, FiO2 fraction of inspired oxygen, MV mechanical ventilation, SOFA Sequential Organ Failure Assessment score, eGFR Estimated Glomerular Filtration Rate